Aurora B: A new promising therapeutic target in cancer

被引:27
|
作者
Chieffi, Paolo [1 ]
机构
[1] Univ Campania, Dipartimento Psicol, Viale Ellitt 31, I-81100 Caserta, Italy
关键词
Aurora kinase; Aurora B; serine-threonine kinase; mitosis; cytokinesis; cancer; inhibitors;
D O I
10.5582/irdr.2018.01018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A critical step for maintenance of genetic stability is chromosome segregation, which requires a high coordination of cellular processes. Loss of mitotic regulation is a possible cause of aneuploidy in human epithelial malignancy and it is thought to create an abnormal nuclear morphology in cancer cells. Serine/threonine protein kinase Aurora B gene plays a regulatory role from G2 to cytokinesis, encompassing key cell cycle events such as centrosome duplication, chromosome bi-orientation, and segregation. The overexpression of Aurora B has been observed in several tumour types, and has been linked with a poor prognosis for cancer patients. Therapeutic inhibition of Aurora kinase showed great promise as a probable anticancer regime because of its important role during cell division.
引用
收藏
页码:141 / 144
页数:4
相关论文
共 50 条
  • [21] Angiogenesis: A promising therapeutic target for ovarian cancer
    Bamias, A.
    Pignata, S.
    Pujade-Lauraine, E.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 84 (03) : 314 - 326
  • [22] KRAS: A Promising Therapeutic Target for Cancer Treatment
    Wu, Hai-Zhou
    Xiao, Jia-Qi
    Xiao, Song-Shu
    Cheng, Yan
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (23) : 2081 - 2097
  • [23] Aurora B kinase as a therapeutic target in acute lymphoblastic leukemia
    Goto, Hiroaki
    Yoshino, Yuki
    Ito, Mieko
    Nagai, Junichi
    Kumamoto, Tadashi
    Inukai, Takesi
    Sakurai, Yukari
    Miyagawa, Naoyuki
    Keino, Dai
    Yokosuka, Tomoko
    Iwasaki, Fuminori
    Hamanoue, Satoshi
    Shiomi, Masae
    Goto, Shoko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (04) : 773 - 783
  • [24] Aurora B kinase as a therapeutic target in acute lymphoblastic leukemia
    Hiroaki Goto
    Yuki Yoshino
    Mieko Ito
    Junichi Nagai
    Tadashi Kumamoto
    Takesi Inukai
    Yukari Sakurai
    Naoyuki Miyagawa
    Dai Keino
    Tomoko Yokosuka
    Fuminori Iwasaki
    Satoshi Hamanoue
    Masae Shiomi
    Shoko Goto
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 773 - 783
  • [25] Aurora kinases: a therapeutic target
    Wilkinson, Robert W.
    MUTAGENESIS, 2010, 25 (06) : 636 - 636
  • [26] Identification of RAD54 homolog B as a promising therapeutic target for breast cancer
    Feng, Jing
    Hu, Juanjuan
    Xia, Ying
    ONCOLOGY LETTERS, 2019, 18 (05) : 5350 - 5362
  • [27] MicroRNA-196b is a promising diagnostic biomarker and therapeutic target in pancreatic cancer
    Igarashi, Hisayoshi
    Kanno, Shinichi
    Ishigami, Keisuke
    Yamamoto, Itaru
    Motoya, Masayo
    Sasaki, Shigeru
    Kimura, Yasutoshi
    Takemasa, Ichiro
    Nosho, Katsuhiko
    Nakase, Hiroshi
    CANCER SCIENCE, 2018, 109 : 705 - 705
  • [28] NFκB/p53 crosstalk-a promising new therapeutic target
    Schneider, Guenter
    Kraemer, Oliver H.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2011, 1815 (01): : 90 - 103
  • [29] THE POTENTIAL OF AURORA KINASE B AS A THERAPEUTIC TARGET IN CHILDHOOD ACUTE LEUKEMIA
    Hartsink-Segers, S.
    Zwaan, M.
    Exalto, C.
    Luijendijk, M.
    Calvert, V.
    Petricoin, E.
    Evans, W.
    Reinhardt, D.
    de Haas, V.
    Caron, H.
    Pieters, R.
    Den Boer, M.
    HAEMATOLOGICA, 2012, 97 : 5 - 6
  • [30] Validating Aurora B as a potential therapeutic target for human hepatocellular carcinoma
    Lin, Zhong-Zhe
    Jeng, Yung-Ming
    Hsu, Hey-Chi
    Cheng, Ann-Lii
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3501S - 3501S